An interventional study of Cleverscope and Laryngoscope / Videolaryngoscope C-MAC® Storz in Anesthesia Intubation Complication and Difficult Intubation, sponsored by Hospital General Universitario de Valencia. Status unknown at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-16.
Sponsored by Hospital General Universitario de Valencia · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Cleverscope is a new medical device that transform a laryngoscope into a videolaryngoscope. previous its commercialization we evaluate its safety and efficacy.
the investigators develope two part study. part I: the investigators collect data of 50 patients prospectively programed for general anesthesia and tracheal intubation without predictors of difficult airways. this patients were intubated with cleverscope, the investigators register best cormack-lehane (glottic vision) obtained with Cleverscope and best cormack obtained with direct laryngoscopy. the investigators register intubation succes rate and any complications during its use and after extubation.
part II: after confirm safety and efficacy in patients without difficult airways (part I) the investigators use Cleverscope for the same pourpose on difficult airways patients. collecting same data . the investigators compare cormack-lehane in this patients with Cleverscope and commercial Videolaryngoscope C-MAC.
Hospital General Universitario de Valencia is the lead sponsor of 11 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
part 1: Scheduled Patients for any kind of surgery with general anesthesia with tracheal intubation without predictors of difficult intubation :
part 2: Scheduled Patients for any kind of surgery with general anesthesia with tracheal intubation with predictors of difficult intubation :
Exclusion Criteria:
Cleverscope is a new videolaryngoscope used for tracheal intubation. in this group we use this device to intubate participants.
Device: Cleverscope
in this group we use a standart comercial device for intubation (laryngoscope or C-MAC) to intubate participants
Device: Laryngoscope / Videolaryngoscope C-MAC® Storz
the device is used in patients without difficult airways predictors
the device is used in patients with difficult airways predictors
Cormack-Lehane Glotic visualization scale (I(complete view, easy to intubate)-IV(no view, imposible to intubate)
degree of glotis visualization
Time frame: intraoperative
First attempt intubation success rate
the rate of traqueal tube pass through vocal cords at first attemps.
Time frame: intraoperative
overall success intubation rate with same device
it could include more attempts
Time frame: intraoperative
time to success
time wasted from device inserted into mouth to inflate tracheal tube
Time frame: intraoperative
complications rate
register complications during intubation or due device usage. like hemorrage, mucosal laceration,
Time frame: intraoperative
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2019 (actual). Primary completion is estimated for Oct 2023, 48 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital General Universitario de Valencia